A Torres, J Dorca, R Zalacain, S Bello, M El-Ebiary, L Molinos, M Arevalo, J Blanquer, R Celis, M Iriberri, E Prats, R Fernandez, R Irigaray and J Serra
Servei de Pneumologia i Al.lergia Respiratoria, Hospital Clinic, Universitat de Barcelona, Spain.

Community-acquired pneumonia (CAP) is an infectious illness that frequently motivates hospital admission when comorbid conditions are present. However, the epidemiology of CAP in relation to the underlying disease of the patients is not well known. We performed a prospective multicenter study with the aim of assessing the clinical characteristics, etiology, and outcome of chronic obstructive pulmonary disease (COPD) patients with CAP. Between October 1992 and December 1994 we studied 124 COPD patients (mean FEV1 40 +/- 11% of predicted, mean FVC/FEV1 49 +/- 10) admitted because of CAP to one of the participating centers. An attempt to obtain an etiologic diagnosis was performed by means of blood cultures (n = 123), sputum cultures (n = 97), pleural fluid cultures (n = 17), protected specimen brush samples (n = 41), percutaneous transthoracic needle aspiration (n = 41), and serology (n = 106). Etiologic diagnosis was achieved in 80 (64%) of cases, however, diagnosis based upon valid techniques was only possible in 73 (59%) cases. The main causal microorganisms were the following: Streptococcus pneumoniae in 32 (43%), Chlamydia pneumoniae in 9 (12%), Hemophilus influenzae in 7 (9%), Legionella pneumophila in 7 (9%), Streptococcus viridans in 3 (4%), Coxiella burnetii in 3 (4%), Mycoplasma pneumoniae in 2 (3%), Nocordia asteroides 2, Aspergillus ssp. 1, and others 10. In three of these cases the etiology was polymicrobial. Bacteremia was present in 19 (15%) cases; S. pneumoniae was the most frequent isolate (13 cases). Antibiotic treatment was modified in 22 cases due to etiologic findings, and in 9 due to therapeutic failure. Ten patients died (8%), and 22 needed mechanical ventilation, the mortality rate in the latter population being 23%. Total or partial resistance of S. pneumoniae to penicillin was observed in 10 of 32 (31%) isolations, and to erythromycin in 2 (6%). The results of this study are important for the standardization of empiric antibiotic strategies in COPD patients with pneumonia.

This article has been cited by other articles:

				H. Kothe, T. Bauer, R. Marre, N. Suttorp, T. Welte, K. Dalhoff, and the Competence Network for Community-Acquired Pneu Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment Eur. Respir. J., July 1, 2008; 32(1): 139 - 146. [Abstract] [Full Text] [PDF]

				H. M. Marriott, L. E. Jackson, T. S. Wilkinson, A. J. Simpson, T. J. Mitchell, D. J. Buttle, S. S. Cross, P. G. Ince, P. G. Hellewell, M. K. B. Whyte, et al. Reactive Oxygen Species Regulate Neutrophil Recruitment and Survival in Pneumococcal Pneumonia Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 887 - 895. [Abstract] [Full Text] [PDF]

				M. I. Restrepo, E. M. Mortensen, J. A. Velez, C. Frei, and A. Anzueto A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU Chest, March 1, 2008; 133(3): 610 - 617. [Abstract] [Full Text] [PDF]

				R. Menendez and A. Torres Treatment Failure in Community-Acquired Pneumonia Chest, October 1, 2007; 132(4): 1348 - 1355. [Abstract] [Full Text] [PDF]

				A. Torres and R. Menendez Mortality in COPD patients with community-acquired pneumonia: who is the third partner? Eur. Respir. J., August 1, 2006; 28(2): 262 - 263. [Full Text] [PDF]

				M. I. Restrepo, E. M. Mortensen, J. A. Pugh, and A. Anzueto COPD is associated with increased mortality in patients with community-acquired pneumonia Eur. Respir. J., August 1, 2006; 28(2): 346 - 351. [Abstract] [Full Text] [PDF]

				J. Rello, A. Rodriguez, A. Torres, J. Roig, J. Sole-Violan, J. Garnacho-Montero, M. V. de la Torre, J. M. Sirvent, M. Bodi, and for the CAPUCI study investigators Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Eur. Respir. J., June 1, 2006; 27(6): 1210 - 1216. [Abstract] [Full Text] [PDF]

				I Alfageme, R Vazquez, N Reyes, J Munoz, A Fernandez, M Hernandez, M Merino, J Perez, and J Lima Clinical efficacy of anti-pneumococcal vaccination in patients with COPD Thorax, March 1, 2006; 61(3): 189 - 195. [Abstract] [Full Text] [PDF]

				M. Falguera, R. Pifarre, A. Martin, A. Sheikh, and A. Moreno Etiology and Outcome of Community-Acquired Pneumonia in Patients With Diabetes Mellitus Chest, November 1, 2005; 128(5): 3233 - 3239. [Abstract] [Full Text] [PDF]

				R Menendez, A Torres, R Zalacain, J Aspa, J J Martin Villasclaras, L Borderias, J M Benitez Moya, J Ruiz-Manzano, F Rodriguez de Castro, J Blanquer, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax, November 1, 2004; 59(11): 960 - 965. [Abstract] [Full Text] [PDF]

				D. Lieberman, D. Lieberman, Y. Gelfer, R. Varshavsky, B. Dvoskin, M. Leinonen, and M. G. Friedman Pneumonic vs Nonpneumonic Acute Exacerbations of COPD Chest, October 1, 2002; 122(4): 1264 - 1270. [Abstract] [Full Text] [PDF]

				F. Arancibia, T. T. Bauer, S. Ewig, J. Mensa, J. Gonzalez, M. S. Niederman, and A. Torres Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa: Incidence, Risk, and Prognosis Arch Intern Med, September 9, 2002; 162(16): 1849 - 1858. [Abstract] [Full Text] [PDF]

				M. Woodhead Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Eur. Respir. J., July 1, 2002; 20(36_suppl): 20S - 27s. [Abstract] [Full Text] [PDF]

				D. Lieberman, D. Lieberman, O. Shmarkov, Y. Gelfer, M. Ben-Yaakov, Z. Lazarovich, and I. Boldur Serological evidence of Legionella species infection in acute exacerbation of COPD Eur. Respir. J., March 1, 2002; 19(3): 392 - 397. [Abstract] [Full Text] [PDF]

				BTS Guidelines for the Management of Community Acquired Pneumonia in Adults Thorax, December 1, 2001; 56(90004): iv1 - 64. [Full Text] [PDF]

				R. MENÉNDEZ, J. CÓRDOBA, P. de la CUADRA, M. J. CREMADES, J. L. LÓPEZ-HONTAGAS, M. SALAVERT, and M. GOBERNADO Value of the Polymerase Chain Reaction Assay in Noninvasive Respiratory Samples for Diagnosis of Community-acquired Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1868 - 1873. [Abstract] [Full Text]